Fortrea Holdings Inc. (FTRE) Stock Grade

About Fortrea Holdings Inc.'s fundamentals

Fortrea Holdings is a $1.8 billion biotechnology company that generated positive free cash flow despite reporting a net loss in its latest annual period, indicating its operations produce cash even as accounting losses mount. Revenue grew modestly at 1.0% year-over-year, while the company's net margin stands at -36.2%, reflecting significant losses relative to sales. The company does not pay a dividend and, given its loss-making status, traditional profitability metrics like P/E ratio and return on equity are not applicable.